Inoviv
Matching patients with the right drugs
Inoviv matches patients with the right drugs. We develop blood tests for major diseases to work out which patients will respond to drugs. Our unique technology, based on targeted proteomics, measures hundreds of molecules in the blood at a fraction of the cost of competitor tests, meaning we can develop tests where others cannot.
Founders
Michael Dove
CEO, Inoviv
Worked in consulting and business development at top pharmaceutical and healthcare organisations
Ernestas Sirka
CSO, Inoviv
Leading researcher in proteomics and clinical test development